EIGER GROUP INTERNATIONAL, INC.

Basic Information

2061 WEBSTER ST
PALO ALTO, CA, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 808460070
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) is an important worldwide cause of liver disease. Current standard of care (SOC) agents are inadequate for most patients, and new virus-spe ...

    STTR Phase II 2011 Department of Health and Human Services
  2. Advancing clemizole for hepatitis C: towards a pre-IND package

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Over 150 million people worldwide are infected with the hepatitis C virus (HCV), which is an important cause of chronic liver disease. Current therapies are inadeq ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government